Medications designed to block a signaling protein called NOTCH3 — which plays a key role in the function and survival…
Articles by Marisa Wexler, MS
A Phase 3 clinical trial testing the experimental cancer vaccine galinpepimut-S (GPS) in people with acute myeloid leukemia (AML), a…
A new Phase 3 clinical trial has officially begun dosing patients to see if an experimental oral therapy can prevent…
VV169, an experimental cellular therapy being developed by Vyriad to treat myeloma, is expected to enter…
Immuneering is preparing to launch a Phase 3 clinical trial to test its experimental…
The first participant has been dosed in an early clinical trial testing the experimental radiation therapy Alpha DaRT in people…
A Phase 1 clinical trial testing the experimental therapy IDE034 in people with various types of cancer, including gynecological…
Johnson & Johnson (J&J) is asking the U.S. Food and Drug Administration (FDA) to approve a combination of two…
ELI-002 7P, an experimental anticancer vaccine designed to induce the immune system to attack a specific cancer protein, can also…
Treatment with the experimental medication eflornithine in combination with the approved chemotherapy Gleostine (lomustine) may help improve survival in people…